SymbolCLNN
NameCLENE INC.
SectorHEALTH CARE
RegionNorth America
IndustryBiotechnology: Pharmaceutical Preparations
Address6550 SOUTH MILLROCK DRIVE,SUITE G50, SALT LAKE CITY, Utah, 84121, United States
Telephone+1 801 - 676-9695
Fax
Email
Websitehttps://www.clene.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001822791
Description

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements).

Additional info from NASDAQ:
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements).

2026-05-05 21:53

Ugwumba Chidozie 🔴 sold 78.7K shares of Clene Inc. (CLNN) at $6.80 Transaction Date: May 01, 2026 | Filing ID: 000018

Read more
2026-05-05 21:06

(30% Negative) CLENE INC. (CLNN) Announces Clinical Trial Timeline Adjustment

Read more
2026-05-05 18:04

New Form 424B5 - Clene Inc. <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001437749-26-014937 <b>Size:</b> 815 KB

Read more
2026-05-05 18:02

New Form 424B5 - Clene Inc. <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001437749-26-014935 <b>Size:</b> 805 KB

Read more
2026-05-05 12:45

Clene Announces $7 Million Underwritten Offering of Common Stock

Read more
2026-05-05 12:00

Clene to Present at Upcoming May Conferences

Read more
2026-05-04 20:02

📋 Symbiosis II LLC (Ex-Board Member) plans to sell 41K shares of Clene Inc (at $6.55 each, total $270K) Filed: May 04, 2026 | ID: 029783

Read more
2026-04-28 20:10

📋 Symbiosis II LLC (Ex-Board Member) plans to sell 57K shares of Clene Inc (at $5.90 each, total $336K) Filed: Apr 28, 2026 | ID: 027924

Read more
2026-04-22 21:55

Ugwumba Chidozie 🔴 sold 65.7K shares of Clene Inc. (CLNN) at $6.14 Transaction Date: Apr 20, 2026 | Filing ID: 000016

Read more
2026-04-18 00:17

Ugwumba Chidozie 🔴 sold 39.2K shares of Clene Inc. (CLNN) at $6.48 Transaction Date: Apr 15, 2026 | Filing ID: 000015

Read more